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ABSTRACT 
Objective: This study emphasis on roll compaction variable and how the processing parameters influence the formation of granules in process of 
formulations of antiretroviral IR Tablet with help of optimization technique.  
Methods: In this present work we aimed to develop a stable pharmaceutical dosage form with anti-retroviral drug tenofovir disoproxil fumarate. % 
retention of granules over # 60 mesh in roll compaction method by sizing with 50G co-mill screen was assessed by optimization and results were 
evaluated by Design expert 12.0 software. Various parameters and optimization of the parameter for formulation for better product was done by 
using 23
Results: Excipients compatibility study gave positive way showing no change in physical appearance of drug-excipients mix. It reviled that drug was 
compatible with excipients used. 
 factorial design and dry granulation technique for manufacturing tablets. Three operating parameters the roller speed, the hydraulic 
pressure and the gap width on the Chamunda CPMRC-200/150 Roll Compactor were varied. The planned response variable for study was % 
retention over #60 ASTM mesh. % retention of granules was calculated by weighing granules on digital electronic balance with respect to how much 
premix material was taken for compaction.  
By formation of granules with required ratio, the value of Compressibility index changed from 29 to 21.89, showed that flow properties were 
improved i.e. from poor to passable. 
Design expert 12.0 gave optimized solution for formation of required quantity of granules. Pareto chart showed envaulted positive and negative 
impact of factors on response as explained in results. 
The results clearly indicate that how granules manufacturing in roll compaction process are influenced by roller pressure, roller gap and speed. 70 
% flakes formation and granules retention were observed with 4000 kg/cm2
Pareto chart clearly indicate major impact is of roller pressure. Comparative dissolution profile graph showed that drug release pattern is similar 
with the innovator tablet. 
 pressure, 1 mm roller gap width and 6 rpm speed of roller.  
A stable, robust tablets were formed at the end of process. 
Conclusion: In this study, by optimizing processing variables stable antiretroviral immediate release oral solid dosage form was formed. 
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INTRODUCTION 
An awesome fact is that since time immemorial i.e. over the past decades 
oral ingestion has long been the most convenient and commonly 
employed route of drug delivery. Oral route is the most preferred route 
of drug administration due to its non-invasive nature, administration 
convenience, and highest patient compliance with low production cost 
and design flexibility. Despite tremendous advancements in drug 
delivery, the oral route retains the ability of being the preferred route for 
the administration of therapeutic agents [1-3]. A granulation process 
step is often mandatory when Active pharmaceutical ingredients or 
formulation excipients have very poor flow property. The flowability of 
powders has major impact in successful formulation of tablets. If the 
powder is with poor flowability, it will lead to segregation of the blend 
and resultantly non-uniform distribution of blend from hopper to feeder 
(force/gravity) and leading to non-uniform die-fill volume and content 
non-uniformity of the prepared tablets [4]. Tenofovir disproxil fumarate 
(TDF) belongs to class of anti-retroviral drugs knows as nucleotide 
analogue reverse transcriptase inhibitors (NtRTIs) which blocks reverse 
transcriptase an enzyme crucial to viral production in HIV-infected 
people. Chemically, TDF is 9[(R)-2-[[bis [[(isopropoxycarbonyl) oxy] 
methoxy] phosphinyl] methoxy] propyl] adenine fumarate [5, 6]. The 
unit dose of the drug is 300 mg. The drug is white to off white 
amorphous powder, is fine, fluffy in nature and exhibits poor flowability. 
Poor flow of powder results in bridging in hopper, arching, rat holing, no 
flow [7]. Granulation, excipient combination has effect on flow ability. 
Hence here granulation method chosen as dry granulation by roller 
compaction method. Roll Compaction/Dry Granulation (RCDG) is a 
granulation method in which is densification/compaction of powder(s) 
is done by passing it between two counter-rotating rollers [8]. The RCDG 
technique has significant effect on fluidity, compressibility and 
compactibility influencing drug release profile and tablet properties. The 
word optimize means perfect, effective or functional as possible. The 
term optimization is often used in pharmacy relative to formulation and 
processing. In general terms, the optimum solution is those value of the 
factors which, when taken together, give the best values for two or more 
dependent variables. Optimal factor values depends on the process 
objective i.e. to maximize process yield or reduce product variability [9]. 
As given in ICH guidelines for quality by design (Qbd), Quality cannot be 
tested into the product that is quality should be built in by design [10]. 
Three operating parameters the roller speed, the hydraulic pressure and 
the Auger speed on the Chamunda CPMRC-200/150 Roll Compactor 
were varied. The planned response variable for study was % retention 
over #60 ASTM mesh. Factorial designs are the design of choice for 
simultaneous determination of the effects of several factors and their 
interactions. Roll compaction/dry granulation (RCDG) is a technique of 
choice for dealing out/processing of physically or chemically moisture 
sensitive drugs, as no liquid binder is essential in the granulation. This 
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literature review exemplifies the advancement and the use of RCDG in 
the production of directly compressible excipients, the compaction of 
drugs and drug formulations. 
The aim of study was to optimize various parameter that affect 
manufacturing of flakes and ultimately reteained granules so the 
final effect will be on stable dosage form [11]. 
MATERIALS AND METHODS 
Tenofovir Disproxil Fumarate (Hetero Lab), Lactose monohydrate 
(Signet Chemicals pvt ltd.), Microcrystalline cellulose Avicel PH 
102(FMC Biopolymer), Sodium starch glycolate (Sigma chemicals 
India), Croscarmellose Sodium (Colorcon pvt ltd.), Magnesium 
stearate (Nitika pharma). The compaction was done on Chamunda 
GMP roll compactor Model-CPMRC 200/150. Screening of flakes into 
granules was done by using Qudro co-mill (M/s Gansons Ltd. India) 
In this study, three aspect of the control of roller compactor were 
adjusted to evaluate the effect on the resultant granulate namely 
roller speed, compaction force and roller gap as discussed. 
Physicochemical characterization of drug  
Bulk density and tapped density of the API (100 gm) was 
determined as per method-1 (USP 30-NF 25, measurement in a 
graduated cylinder) using powder density tester (Electrolab). The 
compressibility index and hausner ratio were studied to determine 
flow property [12]. The drug excipient compatibility was done on 40 
°C/75% RH, the accelerated storage condition [13] [ICH Q1A (R2)] 
for a period of 4 w. 
Formulation of dosage form under optimization of process 
variables of compaction process 
Tablets were formulated by using composition as shown in table 1. 
 
Table 1: Composition of tablet 
S. No. Ingredients for tablet % 
 Compaction Part  
1. Tenofovir Disproxil Fumarate (TDF) 43.47 
2. Lactose Monohydrate 20.86 
3. Microcrystalline Cellulose PH 102 14.28 
4. Magnesium stearate 0.14 
 Lubrication Part  
5. Microcrystalline Cellulose PH 102 14.28 
6. Croscarmellose Sodium 2.86 
7. Sodium Starch Glycolate 2.29 
8. Magnesium stearate 1 
 Core Tablet weight Total-690 mg 100 
9. Opdry II Red 85F25215 3% Weight gain 
 Coated Tablet weight Total-710 mg -- 
 
TDF, Lactose monohydrate were co-sifted through 30# sieve. Then 
microcrystalline cellulose was sifted through 40# sieve. All sifted 
material was mixed in double cone blender for 10 min. Magnesium 
stearate sifted through 60# sieve, then added in blender and mixed 
for 5 min. This premix material was used for compaction. After 
compaction flakes or ribbon produced were sized by using quadro 
co-mill. Screen used was 050 grated (1.20 mm). After that this sized 
material was sifted by using 60# sieve. 60# retained granules were 
collected in polybag and 60# passed fines in another polybag. 
If desired weight of granules is achieved then granules and fines 
were mixed in double cone blender for 5 min. Blended with extra 
granular sifted excipients for 10 min. Finally lubricated with 
Magnesium stearate sifted through 60# sieve for 3 min. This blend 
was compressed by using 16.5 X 8.5 mm punch on Karnavati 
compression machine to form tablets.  
Roll compaction 
A roll compactor generally consists of three major units: a feeding 
system, which conveys the powder to the compaction area 
between the rolls; a compaction unit, where powder is compacted 
between two counter rotating rolls to a ribbon by applying a force; 
and a size reduction unit, for milling the ribbons to the desired 
particle size. Several operational parameters can be 
adjusted/controlled to modify the product granulate; the 
compaction force, the gap width and the milling size, roller rpm, 
auger rpm being the main variables. For this study, the variation in 
the compaction force and the gap width, roller rpm was 
investigated with respect to the quality and quantity of the 
granulate [14]. 
Design of experiments/factorial design for granulation process 
Factorial design is an efficient method of indicating the relative 
significance of number of variable and their interaction. In present 
study, Hydraulic pressure/compaction force, roller speed, roller gap 
width effects were considered. These three variables were 
considered at two level i.e. lower and upper level hence it was a 23
  
 
factorial design. The factors and range for roller compaction 
parameters were as shown in table 2. 
Table 2: Critical process parameter for factorial design 
Factor Name Unit Low level High level 
Factor 1 Roller speed Rpm 3 9 
Factor 2 Hydraulic pressure/Compaction force  kg/cm2 2000 4000 
Factor 3 Roller gap width Mm 1 2 
 
According to factorial design and considering these three variables, 
eight experiments had been performed. The response was % of 
granules over 60# ASTM sieve. Each experiment involved three 
cycles for compaction to achieve desired ratio of granules to fines. 
Finally, after eight batches, optimized process parameters were 
taken for compaction and final batch compacted and evaluated for 
flow properties. This optimized batch granules were taken for 
formulation of tablet. Finally, tablets were coated for 3 % weight 
gain per tablet. Tablets were compressed at parameters as shown in 
table 3. 
The tablets of optimized batch were evaluated for weight variation, 
Assay, disintegration test, In vitro-dissolution test [15]. In vitro-drug 
release study was carried out using USP (Apparatus 2-paddle 
method) dissolution apparatus at 37+0.5oC with constant stirring 
rate of 50 rpm/min. The formulated tablets were tested for drug 
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release in 0.1 N HCl for 45 min. A sample volume of 10 ml was 
withdrawn from each dissolution vessel at regular intervals and 
replaced with equal volume of fresh dissolution medium. The 
withdrawn samples were filtered through 0.45 μm nylon filter. The 
amount of drug released was determined by spectrometer at 259 
nm. Six tablets were taken from each batch for dissolution study and 
average value at each time point was taken for drug release study. 
Film coating of tablets was done by using auto coater to maintain the 
physical and chemical of tablets. The parameter for coating is as 
shown in table 4. 
  
Table 3: Compression parameter for tablet 
S. No. Parameter Limit 
1. Appearance White to off white capsule shape tablet plain on both side 
2. Weight 690 mg+5 % 
3. Thickness 5.80+0.2 mm 
4. Hardness NLT 50 N 
5. Disintegration Test NMT 15 min. 
6. Friability Test NMT 1 % 
 
Table 4: Coating parameter for tablets 
S. No. Parameter Limit 
1. Pan RPM 12-16 rpm 
2. Inlet air Temperature 50-70 oC 
3. Exhaust air Temperature 40-60 oC 
4. Bed Temperature 40-45 oC 
5. Atomizing air pressure 2-4 kg/cm
6. 
2 
Spray pump RPM 5-15 rpm 
7. Spray rate 5-10 ml/min 
8. Spray gun Nozzle diameter 1.5 mm 
 
RESULTS AND DISCUSSION 
Physicochemical characterization of drug was done. The results of 
flow property test indicated poor flow of drug. Hence to improve 
flowability and compressibility dry granulation was done. The 
results were as shown in table 5. 
The results of drug-excipient physical compatibility studies revealed 
that drug was compatible with the excipients studied, as no physical 
change in the appearance of the drug-excipients mix was observed 
as shown in table 6. 
Therefore it was concluded that the drug can be formulated by 
combining drug with mentioned excipients. 
Optimization of roller compactor variables 
The optimization with regard to one or more attributes has always 
been a subject of importance and attention. The word “optimize” 
means perfect, effective or functional as possible. The term 
“optimization” is often used in pharmacy relative to formulation and 
processing. In general terms, the optimum solution is those values of 
the factors which, when taken together, give the “best” values for 
two or more dependent variables. Optimal factor values depend on 
the process objective i.e. to maximize process yield or reduce 
product variability [16, 17].  
Certainly, human input is an essential ingredient of the creative 
process. In addition to the art of formulation, techniques are 
available that can support the scientist’s choice of formulation 
components which will optimize one or more product attributes 
[18, 19].  
Design of experiments run details and observation are tabulated in 
table 7. It was concluded that slow speed for roller provides more 
compaction as it gives sufficient time to form cohesion/bridge 
between particles. Hence slow roller speed provides more 
agglomeration of material. Hydraulic pressure/compaction force has 
direct relation with compaction. 
  
Table 5: Physicochemical characterization of drug 
S. No. Test Specification Results 
1. Description White to off white powder White to off white powder 
2. Solubility Sparingly Soluble in Ethanol and Methanol Complies 
3. Moisture content NMT 1% 0.76% 












5. Melting Point 114-118 °C 114.5 °C 
6. Assay on dried Basis  NLT 97% and NMT 101% w/w 99.5 % w/w 
 
Table 6: Drug excipients compatibility study 
S. No. Combination Ratio Physical appearance Observation at 40 °C/75 % RH 
 1 W 2 W 3 W 4 W 
1. API -- Off white NC NC NC NC 
2. API-Lactose Mono. 1:10 Off white NC NC NC NC 
3. API-Microcrystalline cellulose PH102 1:10 Off white NC NC NC NC 
4. API-Croscarmellose Sodium 1:2 Off white NC NC NC NC 
5. API-Sodium Starch Glycolate 1:2 Off white NC NC NC NC 
6. API-Magnesium Stearate 1:0.5 Off white NC NC NC NC 
Description: NC–No change 
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Table 7: Design of experiment run and observation 
Batch code Factor 1 




) roller gap width (mm) 
Cycles 
(No.) 
Response % retention 
over 60# sieve 
FB1 3 2000 1 3 57% 
FB2 9 2000 1 3 56% 
FB3 3 4000 1 3 72% 
FB4 9 4000 1 3 67% 
FB5 3 2000 2 3 58% 
FB6 9 2000 2 3 55% 
FB7 3 4000 2 3 62% 
FB8 9 4000 2 3 61% 
OB1 6 4000 1 3 70% 
Description: FB–Factorial Batch, OB-Optimized Batch 
 
A high compaction force gave more compacted flakes and resulted into 
more granules. Harder granules obtained when high pressure was 
given while low compaction force provide soft granules in less 
quantity. Less roller gap results into more densification/compaction of 
material. A combined effect of slow roller speed, high hydraulic 
pressure and less roller gap results into high densification/ 
compaction. Three compaction cycles taken in present study. Eight 
factorial design batches taken and evaluated toward highest 
productivity of granules. % retention of granules over 60# sieve varied 
between 55 to 72 % in these eight different trials. As compared to 
roller speed and gap width, more impact is of compaction force. By 
using Design of experiment calculation excel sheet optimum 
parameters value for roller speed, compaction force, roller gap width 
decided to get higher desired response value i.e. % retention over 60 # 
sieve. Compaction force was kept to higher side i.e. 4000 kg/cm2
Pareto chart is a useful tool for showing others the relative size of 
effects. These are useful to separate the “vital few” from the “trivial 
many” issues. Pareto charts are useful in gaining a deeper 
understanding of root cause or discovering possible “high-leverage” 
points to begin to impact change. 
, 
Roller gap kept to lower side i.e. 1 mm. Roller speed was kept at 6 rpm 
by giving emphasis on both on quality as well as output i.e. production 
of granules. Finally, by using this optimum solution for factor, 
compaction was done in optimized batch OB 1. Resultant granules that 
retained over 60 # sieve was 70 %. Rest of manufacturing process was 
done as described previously to formulate tablet. 
Pareto chart 
Here Hydraulic pressure/compaction force factor has a major 
effect on the particle size. It indicates the Hydraulic 
pressure/compaction force factor have most significant effect in 
formation of flakes. Factor below t-limit has non–significant effect. 
Qualitatively it can observe from Pareto chart that the range in 
which turret speed was used have least effect. Roller gap width 
has more effect than Roller speed. 
Hydraulic pressure/compaction force showing positive effect. It can 
be considered to have highest effect for formation of flake. While 
roller speed has least effect.  
Pareto chart was as shown in fig. 1. 
Characterization/evaluation of tablet 
Bulk density of granules was found to be 0.449 gm/ml while tapped 
density was found to be 0.568 gm/ml. Compressibility index and 
hausner’s ratio were calculated from these values i.e. 21.89 and 1.27 
respectively. These micrometrics properties show passable flow 
property and compressibility. Physical characteristics or post 
compression parameters of tablets were evaluated. Results were 
satisfactory and as shown in table 8. 
 
 
Fig. 1: Pareto chart created by design expert v.12.0 related to the given data 
Lahane 
Int J Pharm Pharm Sci, Vol 12, Issue 1, 48-53 
52 
Table 8: Characterization of tablets 
S. No. Property Core tablets Coated tablets 
1. Appearance White colored, biconvex, capsule shaped Orange colored, biconvex, capsule shaped  
2. Average Weight 688–700 mg 708-715 mg 
3. Thickness 5.75–5.84 mm 5.90–5.96 mm 
4. Hardness 50–90 N 120–140 N 
5. Friability 0.09 % -- 
6. Disintegration Time 1 min 45 sec 2 min to 2 min 10 sec  
Assay of tablets was found to be 99.0 to 101.3 %. The drug release from tablets was ranged from 96.5 to 100.1%. Detailed results about dissolution 
study was as shown in table 9. Dissolution profile of formulated tablet was compared with innovator (Viread) Tablets and shown in fig. 2. 
 
Table 9: Dissolution profile at different point of formulation 
Time (min) % Drug release from formulated tablets % Drug release from Innovator (Viread) 
0 0 0 
5 40.2 37.2 
10 61.9 56.1 
15 79.5 73.5 
30 97.8 97.2 
45 100.3 99.3 
Note-Results of dissolution are average value. 
 
 
Fig. 2: Comparison of dissolution profile of innovator with test 
 
CONCLUSION 
The use of dry granulation, that is, Roller Compaction, has increased 
recently in the development and manufacturing of pharmaceutical 
dosage forms. In present study, a successful attempt has been made to 
formulate an antiretroviral molecule into immediate release tablet by 
dry granulation/roller compaction method. Critical variable having 
impact on compaction process has been identified and controlled to 
produce desired target response. Pareto chart is a useful tool for 
showing others the relative size of effects. It gives deeper understanding 
that root cause in formation of flakes and retained granules is majorly 
compaction force after that distance between rollers is major factor. 23
With respect to Quality by Design requirements, these results 
demonstrate that it is possible to control Critical Process Parameters 
in order to achieve required retained granules % and granules 
properties. 
 
factorial design, Design expert software, Pareto chart are the new 
technique to find out important factor that impact quality. 
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